4 Results for "

20-HETE formation

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "20-HETE formation" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-101016
CAS No.: 34450-18-5
Purity:  ≥98.0%
Research Areas:  

Cardiovascular Disease

17-ODYA is a CYP450 ω-hydroxylase inhibitor. 17-ODYA is also a potent inhibitor (IC50<100 nM) of the formation of 20-hydroxyeicosatetraenoic acid (20-HETE), epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids by rat renal cortical microsomes incubated with arachidonic acid. 17-ODYA completely attenuates the isoproterenol (ISO)-induced apoptosis, and necrosis in cultured cardiomyocytes . 17-ODYA is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-156875
CAS No.: 2472030-28-5
Target:  

Cytochrome P450

Research Areas:  

Others

20-HETE inhibitor-1 (comp 83) is a 20-HETE formation inhibitor
loading...
    loading...
Cat. No.: HY-101016R
CAS No.: 34450-18-5
17-ODYA (Standard) is the analytical standard of 17-ODYA. This product is intended for research and analytical applications. 17-ODYA is a CYP450 ω-hydroxylase inhibitor. 17-ODYA is also a potent inhibitor (IC50<100 nM) of the formation of 20-hydroxyeicosatetraenoic acid (20-HETE), epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids by rat renal cortical microsomes incubated with arachidonic acid. 17-ODYA completely attenuates the isoproterenol (ISO)-induced apoptosis, and necrosis in cultured cardiomyocytes[1][2][3]. 17-ODYA is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-182771
CAS No.: 3119850-82-4
Target:  

Cytochrome P450

Research Areas:  

Metabolic Disease

20-HETE IN-3 is an orally bioavailable 20-HETE synthesis inhibitor. 20-HETE IN-3 can be used in the research of obesity .
loading...
    loading...